EPA:ORP - Euronext Paris - Matif - FR001400NLM4 - Common Stock - Currency: EUR
EPA:ORP (7/2/2024, 5:28:19 PM)
12.465
+0.15 (+1.24%)
The current stock price of ORP.PA is 12.465 EUR. In the past month the price decreased by -11.26%. In the past year, price decreased by -99.32%.
Symbol | Company Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
EMEIS.PA | EMEIS SA | N/A | 1.65B | ||
CLARI.PA | CLARIANE SE | N/A | 1.43B | ||
GDS.PA | RAMSAY GENERALE DE SANTE SA | N/A | 1.19B | ||
RHK.DE | RHOEN-KLINIKUM AG | 21.33 | 857.09M | ||
GHC.MI | GAROFALO HEALTH CARE SPA | 15.23 | 480.77M | ||
M12.DE | M1 KLINIKEN AG | 17.85 | 287.53M | ||
LNA.PA | LNA SANTE | 11.36 | 259.18M | ||
MED.DE | MEDICLIN AG | 5.38 | 140.60M | ||
LIK.DE | LIMES SCHLOSSKLINIKEN AG | 22.78 | 97.44M | ||
MAK.DE | MATERNUS-KLINIKEN AG | N/A | 33.34M | ||
EIF.DE | MEDNATION AG | 78.5 | 4.90M |
Orpea SA engages in the operation of geriatric healthcare facilities. The company is headquartered in Puteaux, Ile-De-France and currently employs 76,160 full-time employees. The company went IPO on 2002-04-16. Through its wholly owned subsidiary, Clinea, the Company also offers a range of other services, from outpatient treatment, post-operation care and physical therapy, to nursing, geriatric care, psychiatric services and long-term care homes. The firm operates a number of wholly owned subsidiaries, including Clinea, Villers Services SA, Residence La Cheneraie SAS, Carina SA, Super Aix SCI, Emcejidey SA, Maison de Retraite Paul Cezanne SA and Inoges AG, among others. The company operates through Vitalis, Senevita, Dr. Dr. Wagner group and Anavita, operator of nursing homes in the Czech Republic.
EMEIS SA
12 Rue Jean Jaures, Puteaux Cedex
Puteaux ILE-DE-FRANCE FR
Employees: 76160
Phone: 33147757807
The current stock price of ORP.PA is 12.465 EUR. The price increased by 1.24% in the last trading session.
The exchange symbol of EMEIS SA is ORP and it is listed on the Euronext Paris - Matif exchange.
ORP.PA stock is listed on the Euronext Paris - Matif exchange.
9 analysts have analysed ORP.PA and the average price target is 170.74 EUR. This implies a price increase of 1269.72% is expected in the next year compared to the current price of 12.465. Check the EMEIS SA stock analysts ratings, price target forecast and up-and down grades for more detailed information.
EMEIS SA (ORP.PA) has a market capitalization of 1.98B EUR. This makes ORP.PA a Small Cap stock.
EMEIS SA (ORP.PA) currently has 76160 employees.
EMEIS SA (ORP.PA) has a support level at 11.09 and a resistance level at 12.47. Check the full technical report for a detailed analysis of ORP.PA support and resistance levels.
The Revenue of EMEIS SA (ORP.PA) is expected to grow by 6.41% in the next year. Check the estimates tab for more information on the ORP.PA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
ORP.PA does not pay a dividend.
EMEIS SA (ORP.PA) will report earnings on 2024-07-24.
The PE ratio for EMEIS SA (ORP.PA) is 1.2. This is based on the reported non-GAAP earnings per share of 10.36 and the current share price of 12.465 EUR. Check the full fundamental report for a full analysis of the valuation metrics for ORP.PA.
ChartMill assigns a technical rating of 1 / 10 to ORP.PA. When comparing the yearly performance of all stocks, ORP.PA is a bad performer in the overall market: 96.95% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to ORP.PA. ORP.PA has a medium profitability rating, but doesn't score so well on its financial health evaluation.
Over the last trailing twelve months ORP.PA reported a non-GAAP Earnings per Share(EPS) of 10.36. The EPS increased by 360.39% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 26.07% | ||
ROA | 9.74% | ||
ROE | 71.82% | ||
Debt/Equity | 4.3 |
ChartMill assigns a Buy % Consensus number of 49% to ORP.PA. The Buy consensus is the average rating of analysts ratings from 9 analysts.
For the next year, analysts expect an EPS growth of 99.7% and a revenue growth 6.41% for ORP.PA